---
figid: PMC4332970__13045_2014_99_Fig6_HTML
figlink: /pmc/articles/PMC4332970/figure/Fig6/
number: F6
caption: Proposed model in which gal-3 mediates Wnt/β-catenin signaling in the BMM-induced
  drug resistance of AL. hBM-MSCs induce gal-3 expression in ALCs. Gal-3 mediates
  Akt phosphorylation, which promotes phosphorylation of GSK-3β and thus decreases
  its activity. Inactivation of GSK-3β leads to a reduction in β-catenin degradation.
  Stabilized β-catenin translocates to the nucleus and activates transcription of
  its specific target genes, which ultimately leads to drug resistance in ALCs.
pmcid: PMC4332970
papertitle: Galectin-3 mediates bone marrow microenvironment-induced drug resistance
  in acute leukemia cells via Wnt/β-catenin signaling pathway.
reftext: Kaimin Hu, et al. J Hematol Oncol. 2015;8:1.
pmc_ranked_result_index: '10702'
pathway_score: 0.9589499
filename: 13045_2014_99_Fig6_HTML.jpg
figtitle: Proposed model in which gal-3 mediates Wnt/Beta-catenin signaling in the
  BMM-induced drug resistance of AL
year: '2015'
organisms: Homo sapiens
ndex: 23064001-deaa-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4332970__13045_2014_99_Fig6_HTML.html
  '@type': Dataset
  description: Proposed model in which gal-3 mediates Wnt/β-catenin signaling in the
    BMM-induced drug resistance of AL. hBM-MSCs induce gal-3 expression in ALCs. Gal-3
    mediates Akt phosphorylation, which promotes phosphorylation of GSK-3β and thus
    decreases its activity. Inactivation of GSK-3β leads to a reduction in β-catenin
    degradation. Stabilized β-catenin translocates to the nucleus and activates transcription
    of its specific target genes, which ultimately leads to drug resistance in ALCs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - PIK3R5
  - PIK3CB
  - AKT1
  - PIK3R3
  - CCND1
  - AKT3
  - MYC
  - AKT2
  - PIK3CG
  - PIK3R6
  - PIK3CA
  - BIRC5
  - PIK3CD
  - PIK3R4
genes:
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: c-Myc,CyclinD1,
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: c-Myc,CyclinD1,
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals: []
diseases: []
figid_alias: PMC4332970__F6
redirect_from: /figures/PMC4332970__F6
figtype: Figure
---
